secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2025-03-06T23:59:59+00:00
Accession:  0001411685-25-000023
Event type: litigation
Sentiment:  negative
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vistagen sued by pro se plaintiffs over alleged misleading clinical trial disclosures
--------------------------------------------------------------------------------

- John Cesario and David Preka filed lawsuit on Feb 13, 2025 (Case No. 4:25-cv-01510) in Northern District of California.
- Complaint alleges violations of Sections 10(b), Rule 10b-5, Sections 11 and 17(a) over public disclosures on clinical trials.
- Plaintiffs seek compensatory, punitive damages, fees, and costs.
- Vistagen believes allegations are wholly without merit and intends to defend vigorously.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000141168525000023/0001411685-25-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000141168525000023/vtgn-20250303.htm
  HTML page:      https://secwatch.observer/filing/0001411685-25-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer